NXPLNasdaqTelephone Communications (No Radiotelephone)Fiscal year ends December 31
NextPlat Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$9.10−0.40 (-4.22%)
Close on Oct 19, 2026
- Market cap
- $24.64M
- P/E (TTM)
- –
- Dividend yield
- –
NextPlat Corp revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare Operations [Member] | $7.80M | $6.66M | $9.03M | $10.05M | $9.12M | $10.92M | $12.65M | $11.53M | $13.48M | $14.63M | $14.42M | $12.36M | 65.7% | -14.4% |
| E-Commerce [Member] | $4.08M | $3.20M | $3.78M | $3.70M | $4.12M | $3.01M | $3.58M | $3.83M | $3.51M | $2.87M | $2.21M | $2.93M | 34.3% | -1.0% |
| E-Commerce Revenue [Member] | $4.08M | $3.20M | $3.78M | $3.70M | $4.12M | $3.01M | $3.58M | $3.83M | $3.51M | $2.87M | – | – | 34.3% | -1.0% |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare Operations [Member] | $1.01M | $24.00K | -$2.03M | -$1.09M | -$1.14M | -$945.00K | -$1.13M | -$5.93M | -$9.30M | -$397.00K | -$13.30M | -$1.36M | -188.8% |
| E-Commerce [Member] | $200.00K | -$84.00K | -$1.67M | -$901.00K | $88.00K | -$158.00K | -$1.22M | -$2.13M | -$1.66M | -$1.51M | -$1.92M | -$2.18M | +127.3% |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacy Prescription and Other Revenue, Net of PBM Fees [Member] | $5.56M | $4.78M | $7.95M | $9.50M | $8.17M | $9.49M | $10.99M | $9.08M | $10.52M | $11.32M | $11.52M | $9.89M | 46.8% | -31.9% |
| E-Commerce Revenue [Member] | $4.08M | $3.20M | $3.78M | $3.70M | $4.12M | $3.01M | $3.58M | $3.83M | $3.51M | $2.87M | $2.21M | $2.93M | 34.3% | -1.0% |
| Pharmacy Contract Revenue [Member] | $2.24M | $1.87M | – | – | $947.00K | $1.43M | – | – | – | – | – | – | 18.8% | +136.4% |
| E-Commerce [Member] | – | – | – | $3.70M | $4.12M | $3.01M | $3.58M | $3.83M | $3.51M | $2.87M | $2.21M | $2.93M | – | – |
| Pharmacy Prescription, Other Revenue and E-Commerce [Member] | – | – | – | – | – | $13.10M | – | – | – | $14.19M | $13.74M | $12.82M | – | – |
| Service [Member] | – | – | $1.58M | $653.00K | $977.00K | $1.44M | $1.71M | $2.50M | $2.96M | $3.37M | $2.87M | $2.50M | – | – |
| Product [Member] | – | – | $11.22M | $13.10M | $12.26M | $13.08M | $14.53M | $12.87M | $14.03M | $14.12M | $13.77M | $12.79M | – | – |
| Pharmacy 340B Contract [Member] | – | – | $1.08M | $555.00K | $947.00K | $1.43M | $1.67M | $2.46M | $2.96M | $3.30M | $2.90M | $2.47M | – | – |
By region
From the segment and revenue-disaggregation notes of NextPlat's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.